Effect of selective laser trabeculoplasty and standard medical treatment on day tension curve and intra-ocular pressure
ISRCTN | ISRCTN17339574 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN17339574 |
Secondary identifying numbers | N0183168499 |
- Submission date
- 29/09/2006
- Registration date
- 29/09/2006
- Last edited
- 19/05/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mrs M Nagar
Scientific
Scientific
Consultant Ophthalmologist
The Mid Yorkshire Hospitals NHS Trust
Clayton eye Centre
Clayton Hospital
Wakefield
WF1 4EE
United Kingdom
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Not Specified |
Scientific title | |
Study objectives | What is the effect of selective laser trabeculoplasty and Xalatan eye drops on intra-ocular pressure fluctuation? An earlier study (see http://www.controlled-trials.com/ISRCTN77145641) explored whether 90, 180 or 360 degrees of laser treatment was more effective. This study looks at effect throughout the day of 360 degrees of treatment. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Eye Diseases: Glaucoma |
Intervention | Randomised Clinical Trial. Randomisation to [A] 360 degree selective laser trabeculoplasty or [B] standard medical treatment. |
Intervention type | Other |
Primary outcome measure | Intra-ocular pressure, and daytime tension curve. |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/07/2005 |
Completion date | 01/07/2006 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | Total target recruitment = 40 patients |
Key inclusion criteria | Patients with newly diagnosed early glaucoma or ocular hypertension. |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 01/07/2005 |
Date of final enrolment | 01/07/2006 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Consultant Ophthalmologist
Wakefield
WF1 4EE
United Kingdom
WF1 4EE
United Kingdom
Sponsor information
Record Provided by the NHSTCT Register - 2006 Update - Department of Health (UK)
Government
Government
The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)20 7307 2622 |
---|---|
dhmail@doh.gsi.org.uk | |
Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
The Mid Yorkshire Hospitals NHS Trust (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/04/2009 | Yes | No |